Bottom line
INDL vs LABD: the short answer
INDL (Direxion Daily MSCI India Bull 2X ETF) and LABD (Direxion Daily S&P Biotech Bear 3X ETF) are both etfs.
LABD is cheaper at 1.07% vs 1.23% — a difference of $16 a year per $10,000 invested.
Over five years, INDL returned +7.2% a year vs −37.7% for LABD.
Updated Nov 19, 2026
INDL vs LABD side by side
| INDL | LABD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.23% | 1.07% |
| Annual cost per $10k | $123 | $107 |
| 10-yr cost on $10k (prospectus) | $1,489 | $1,316 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −3.2% | −70.0% |
| 5-yr return (annualized) | +7.2% | −37.7% |
| 10-yr return (annualized) | +1.6% | −54.4% |
| Best quarter | +58.5% | +75.0% |
| Worst quarter | −79.9% | −75.2% |
| Net assets (fund) | $57.0M | $54.2M |
| Number of holdings | 8 | 10 |
| Portfolio turnover | 61% | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | INDL | LABD | Difference |
|---|---|---|---|
| 2025 | −3.2% | −70.0% | +66.8% |
| 2024 | +7.6% | −21.6% | +29.2% |
| 2023 | +26.3% | −41.6% | +67.9% |
| 2022 | −23.3% | −32.9% | +9.6% |
| 2021 | +40.6% | +2.1% | +38.4% |
| 2020 | −36.4% | −89.8% | +53.3% |
| 2019 | +2.3% | −70.6% | +72.9% |
| 2018 | −33.9% | −7.1% | −26.8% |
| 2017 | +128.2% | −75.6% | +203.9% |
| 2016 | −15.9% | −39.1% | +23.2% |
Source: Fund prospectus bar charts
Holdings overlap
7 of INDL's top 8 holdings also appear in LABD's top 10.
| Holding | INDL | LABD |
|---|---|---|
| Dreyfus | 28.28% | 40.47% |
| Goldman Financial | 14.08% | 52.74% |
| Goldman Sachs Liq Es Fd A | 5.17% | 26.30% |
| N/a | 1.11% | -6.37% |
| N/a | 0.59% | -6.37% |
| N/a | -2.48% | -6.37% |
| N/a | -5.13% | -6.37% |
Source: SEC Form N-PORT
INDL top 10
- iShares Trust — 59.51%
- Dreyfus — 28.28%
- Goldman Financial — 14.08%
- Goldman Sachs Liq Es Fd A — 5.17%
- N/a — 1.11%
- N/a — 0.59%
- N/a — -2.48%
- N/a — -5.13%
LABD top 10
- Goldman Financial — 52.74%
- Dreyfus — 40.47%
- Goldman Sachs Liq Es Fd A — 26.30%
- Dreyfus — 18.03%
- N/a — 2.98%
- N/a — 1.43%
- N/a — -1.55%
- N/a — -4.11%
- N/a — -4.88%
- N/a — -6.37%
FAQ
What is the difference between INDL and LABD?
Which is cheaper, INDL or LABD?
Should I own both INDL and LABD?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.